Storage and handling
Room temperature. Avoid excessive heat. Protect from freezing.
Additive Solution Formula 3
- Manufacturer
- Terumo BCT Ltd | Terumo BCT Ltd.
- Effective date
- 2025-01-22
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 21:23:59
Label at a glance#
ProductAS 3
Active ingredientDextrose Monohydrate, SODIUM CITRATE, UNSPECIFIED FORM, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate, Adenine
Label structure7 sections
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Catalog # 777965-000
6 x 6 x 100 mL units
NDC 14537-966-10
Canada DIN 02324393
DESCRIPTION SECTION
Intended for use only with Trima and Trima Accel automated red blood cell apheresis devices and Atreus Whole Blood Processing System. See Operator's Manuals for additional information and complete usage instructions.
Sterile. Non-pyrogenic. Do not use unless the solution is clear and the container is intact. Rx only.
Single use container.
SPL UNCLASSIFIED SECTION
Caution: Not for direct intravenous infusion.
Recommended storage
Room temperature.
Avoid excessive heat. Protect from freezing.
HOW SUPPLIED SECTION
Each 100 mL contains:
| Dextrose Monohydrate USP | 1.10 g |
| Sodium Citrate Dihydrate USP | 0.588 g |
| Sodium Chloride USP | 0.410 g |
| Monobasic Sodium Phosphate Monohydrate USP | 0.276 g |
| Citric Acid Monohydrate USP | 0.042 g |
| Adenine USP | 0.030 g |
| In Water for Injection USP |
SPL UNCLASSIFIED SECTION
Manufactured by Terumo BCT, Inc.
10811 W. Collins Ave., Lakewood CO 80215, USA
Dist in Canada: Terumo BCT (Canada), Inc., 4 Robert Speck Pkwy,
Ste. 1500, Mississauga, ON, Canada L4Z1S1
777965-065
Lot
Expiry Date
PRINCIPAL DISPLAY PANEL - 100 mL Label
Additive Solution Formula 3 AS-3
Catalog # 777965-000
6 x 6 x 100 mL units
NDC 14537-966-10
Canada DIN 02324393
Intended for use only with Trima and Trima Accel automated red blood cell
apheresis devices and Atreus Whole Blood Processing System. See Operator's
Manuals for additional information and complete usage instructions.
Sterile. Non-pyrogenic. Do not use unless the solution is clear and
the container is intact. Rx only. Single use
container.
Caution: Not for direct intravenous infusion.
Recommended storage: Room temperature.
Avoid excessive heat. Protect from freezing.
Each 100 mL contains:
| Dextrose Monohydrate USP | 1.10 g |
| Sodium Citrate Dihydrate USP | 0.588 g |
| Sodium Chloride USP | 0.410 g |
| Monobasic Sodium Phosphate Monohydrate USP | 0.276 g |
| Citric Acid Monohydrate USP | 0.042 g |
| Adenine USP | 0.030 g |
| In Water for Injection USP |
Manufactured by Terumo BCT, Inc.
10811 W. Collins Ave., Lakewood CO 80215, USA
Dist in Canada: Terumo BCT (Canada), Inc., 4 Robert Speck Pkwy,
Ste. 1500, Mississauga, ON, Canada L4Z1S1
TERUMOBCT
777965-065
Lot
Expiry Date
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 14537-966 | AS 3 (DEXTROSE MONOHYDRATE, SODIUM CITRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE AND ADENINE) INJECTION, SOLUTION [TERUMO BCT LTD] | 4 | Legacy NDC | 20250124_5f51ab45-2ff0-4b07-9fb9-69789da65d4b.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Adenine | ACTIVE INGREDIENT | JAC85A2161 | 2 | |
| Citric Acid Monohydrate | ACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| Dextrose Monohydrate | ACTIVE INGREDIENT | LX22YL083G | 2 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| Sodium Citrate | ACTIVE INGREDIENT | 1Q73Q2JULR | 2 | |
| Sodium Phosphate, Monobasic, Monohydrate | ACTIVE INGREDIENT | 593YOG76RN | 2 | |
| Adenine | ACTIVE MOIETY | JAC85A2161 | 2 | |
| Anhydrous Citric Acid | ACTIVE MOIETY | XF417D3PSL | 2 | |
| Anhydrous Dextrose | ACTIVE MOIETY | 5SL0G7R0OK | 2 | |
| Chloride Ion | ACTIVE MOIETY | Q32ZN48698 | 2 | |
| Phosphate Ion | ACTIVE MOIETY | NK08V8K8HR | 2 |
Products#
Every source-derived product name is available through these pages.
- AS 3
- Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine
- Dextrose Monohydrate
- Anhydrous Dextrose
- SODIUM CITRATE, UNSPECIFIED FORM
- Anhydrous Citric Acid
- Sodium Chloride
- Chloride Ion
- Sodium Phosphate, Monobasic, Monohydrate
- Phosphate Ion
- Citric Acid Monohydrate
- Adenine
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 14537-966 | 14537-966-10, 14537-966-20 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dextrose Monohydrate | LX22YL083G | ACTIB |
| SODIUM CITRATE, UNSPECIFIED FORM | 1Q73Q2JULR | ACTIB |
| Sodium Chloride | 451W47IQ8X | ACTIB |
| Sodium Phosphate, Monobasic, Monohydrate | 593YOG76RN | ACTIB |
| Citric Acid Monohydrate | 2968PHW8QP | ACTIM |
| Adenine | JAC85A2161 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d1648482-80f2-47c3-b1ed-70ea3126e011 | 5f51ab45-2ff0-4b07-9fb9-69789da65d4b | 2025-10-29 | 5f51ab45-2ff0-4b07-9fb9-69789da65d4b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.